E
Lyell Immunopharma, Inc. LYEL
$0.5854 -$0.0209-3.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -53.08% -99.87% -99.89% -99.92% -99.85%
Total Other Revenue -- -- -- -- --
Total Revenue -53.08% -99.87% -99.89% -99.92% -99.85%
Cost of Revenue -- -- -- -- --
Gross Profit -53.08% -99.87% -99.89% -99.92% -99.85%
SG&A Expenses -22.31% -36.77% -40.02% -40.10% -42.90%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -31.17% -15.13% 20.54% 38.51% 33.38%
Total Operating Expenses -11.06% -13.57% -12.74% -9.64% -9.18%
Operating Income 11.04% -7.12% -7.41% -32.35% -31.88%
Income Before Tax -46.18% -7.31% -0.36% -25.51% -28.13%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -46.18% -7.31% -0.36% -25.51% -28.13%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -46.18% -7.31% -0.36% -25.51% -28.13%
EBIT 11.04% -7.12% -7.41% -32.35% -31.88%
EBITDA 11.75% -8.22% -8.00% -35.25% -33.96%
EPS Basic -36.57% -5.48% 1.26% -23.66% -25.86%
Normalized Basic EPS 32.74% 19.44% 21.11% 4.71% -53.59%
EPS Diluted -36.57% -5.48% 1.26% -23.66% -25.86%
Normalized Diluted EPS 32.74% 19.44% 21.11% 4.71% -53.59%
Average Basic Shares Outstanding 4.18% 1.82% 1.62% 1.50% 1.58%
Average Diluted Shares Outstanding 4.18% 1.82% 1.62% 1.50% 1.58%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings